Experimental pneumococcal pleural empyema model: the effect of moxifloxacin
Author(s) -
Jacob Strahilevitz
Publication year - 2003
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkg094
Subject(s) - moxifloxacin , empyema , medicine , streptococcus pneumoniae , pleural empyema , pasteurella multocida , antibacterial agent , surgery , microbiology and biotechnology , antibiotics , biology , bacteria , genetics
Pleural empyema is a serious complication of pneumonia, the optimal therapy of which is still unknown. The objective of this study was to evaluate the use of moxifloxacin in this condition.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom